Context: Systemic autoimmune and inflammatory diseases often manifest oral lesions in
their earliest stages, and early diagnosis, which may be spurred by a dental examination, is …

Introduction: Belimumab is a fully humanised mAb against B lymphocyte stimulator (B-LyS).
It is the first biological drug licensed and approved by the US FDA and the European …

Summary VGX‐1027 [(S, R)‐3‐phenyl‐4, 5‐dihydro‐5‐isoxasole acetic acid] is a small
molecule compound with immunomodulatory properties, which favourably influences the …

CME Educational Objectives 1. Learn the symptoms, diagnostic procedures, and prevalence
of neuropsychiatric lupus (NPSLE). 2. Understand the current hypotheses regarding the …

New therapeutics in systemic lupus erythematosus : Current Opinion in Rheumatology New
therapeutics in systemic lupus erythematosus : Current Opinion in Rheumatology Log in or …

Introducción El lupus eritematoso sistémico (LES) es una enfermedad autoinmune
compleja, en cuya fisiopatología destaca la hiperactividad de las células B. En esta entidad …

За последние годы достигнуты значительные успехи в лечении системной красной
волчанки (СКВ), однако решены далеко не все вопросы. Арсенал лекарственных …

In the past years considerable progress has been made in the treatment of systemic lupus
erythe-matosus; however, not all questions have been answered. The range of medications …

Abstract Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of elusive
origin and characterised by polyclonal B cell hyperactivity and the production of pathogenic …